Salt la conţinut

Oncologie

Toleranța la anemia normovolemică

Liberal or restrictive transfusion in high-risk patients after hip surgery. (se deschide o fereastră nouă)

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators.

Sursă‎: N Engl J Med 2011;365(26):2453-62.

Index‎: PubMed 22168590

DOI‎: 10.1056/NEJMoa1012452

https://www.ncbi.nlm.nih.gov/pubmed/22168590 (se deschide o fereastră nouă)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (se deschide o fereastră nouă)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Sursă‎: Transfusion 2016;56(10):2438-42.

Index‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (se deschide o fereastră nouă)

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. (se deschide o fereastră nouă)

Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

Sursă‎: N Engl J Med 1999;340(6):409-17.

Index‎: PubMed 9971864

DOI‎: 10.1056/NEJM199902113400601

https://www.ncbi.nlm.nih.gov/pubmed/9971864 (se deschide o fereastră nouă)

Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? (se deschide o fereastră nouă)

Leal-Noval SR, Muñoz-Gómez M, Jiménez-Sánchez M, Cayuela A, Leal-Romero M, Puppo-Moreno A, Enamorado J, Arellano-Orden V.

Sursă‎: Intensive Care Med 2013;39(3):445-53.

Index‎: PubMed 23184038

DOI‎: 10.1007/s00134-012-2757-z

https://www.ncbi.nlm.nih.gov/pubmed/23184038 (se deschide o fereastră nouă)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (se deschide o fereastră nouă)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Sursă‎: Cancer Treat Rev 2016;46:1-8.

Index‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (se deschide o fereastră nouă)

Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. (se deschide o fereastră nouă)

Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Sursă‎: Transfusion 2014;54(10 Pt 2):2678-86.

Index‎: PubMed 25135770

DOI‎: 10.1111/trf.12825

https://www.ncbi.nlm.nih.gov/pubmed/25135770 (se deschide o fereastră nouă)

Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial. (se deschide o fereastră nouă)

Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, Petrcich W, Ramsay T, Walker I, Xenocostas A, Tinmouth A, Fergusson D

Sursă‎: J Clin Oncol 2020;38(13):1463-73.

Index‎: PubMed 32083994

DOI‎: 10.1200/JCO.19.01836

https://www.ncbi.nlm.nih.gov/pubmed/32083994 (se deschide o fereastră nouă)

Transfusion indications for patients with cancer. (se deschide o fereastră nouă)

Watkins T, Surowiecka MK, McCullough J.

Sursă‎: Cancer Control 2015;22(1):38-46.

Index‎: PubMed 25504277

https://www.ncbi.nlm.nih.gov/pubmed/25504277 (se deschide o fereastră nouă)